Tommy and Melodie Sevilla share the story of their T1D daughter Gracie’s diagnosis, treatment, and achievement. “Gracie’s leg hurt again.…
Read More »Martin Hensel
Hospitals often use outdated care practices despite a large body of knowledge about the importance of glycemic management in hospitalized…
Read More »
“Making diabetes data more accessible, meaningful, and actionable” is the Tidepool mission. This not-for-profit organization began with a father’s…
Read More »
Paresh Dandona, MD, Ph.D. (bio) has been passionate about blood sugar control since he became a Fellow in London in…
Read More »
Diabeloop has made rapid progress since its founding in 2015 and has achieved an important milestone with receipt of CE…
Read More »
I was originally born in Canada and left at five years old to go to North Africa with my father.…
Read More »
Over a decade ago, the US approval and launch of pramlintide (Symlin® AstraZeneca) brought a lot of excitement because of…
Read More »
Reports on the health consequences of cannabis use are mixed. There have however been studies done that suggest there are…
Read More »
With a focus on building community, peer-led information exchange, creative health programs, and social support, the Family Centre does diabetes…
Read More »
The Eversense CGM system consists of an implanted sensor, a removable transmitter, and a smartphone app. CGM adoption has been…
Read More »
The relationship between gut bacteria, genetics, and T1D risk is a complicated picture, but multiple studies indicate that gut bacteria…
Read More »
Cardio vascular disease is the leading cause of mortality in people with T1D. This relates strongly to insulin resistance and…
Read More »
Rapid-acting insulins such as Novolog and Humalog often show peak insulin levels up to 3 hours after injection. In this…
Read More »
SFC Fluidics has used a succession of SBIR grants and a recent partnership with JDRF to develop a patch pump…
Read More »
Metformin, an oral agent that works for hyperglycemia, is typically prescribed for type 2 diabetes patients to increase insulin sensitivity…
Read More »
Sodium-glucose co-transporter 2 (SGLT2) inhibitors, also called gliflozin drugs, are a new class of diabetic medications. They work by reducing…
Read More »
The ultimate goal of Automated Insulin Dosing (aka artificial pancreas) requires sensing BG levels, then calculating and delivering insulin in…
Read More »
FDA Biosimilars Policy Ensures High Insulin Costs & Declining Public Health But Change is Coming
Read More »
Insulin is widely used to treat diabetes, and it may be beneficial in treating other conditions.
Read More »
Diabetes can be particularly confusing for a teen where it can be easy to write off initial symptoms of low…
Read More »